Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Carson PE"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2385
Tytuł:
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy:
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, CO, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Jacob R; Patient Representative, Dublin, OH, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, MA, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, MD, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, NH, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA.; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Dec; Vol. 22 (12), pp. 2175-2186. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji:
Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Heart Failure*/diagnosis
Heart Failure*/epidemiology
Heart Failure*/etiology
Heart Failure*/therapy
Terminology as Topic*
Clinical Trials as Topic/*standards
Cardiac Resynchronization Therapy ; Cardiovascular Agents/therapeutic use ; Comorbidity ; Consensus ; Defibrillators, Implantable ; Diagnostic Techniques, Cardiovascular/standards ; Electric Countershock/instrumentation ; Endpoint Determination/standards ; Europe ; Hospitalization ; Humans ; Patient Reported Outcome Measures ; Quality of Life ; Treatment Outcome ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.
Autorzy:
Maeda, Makiko (AUTHOR)
Humber, Douglas (AUTHOR)
Hida, Eisuke (AUTHOR)
Ohtani, Tomohito (AUTHOR)
Wang, Guannan (AUTHOR)
Wu, Tong (AUTHOR)
Takeda, Shiori (AUTHOR)
Situ, Jacinta N. (AUTHOR)
Hayashi, Jun (AUTHOR)
Nonen, Shinpei (AUTHOR)
Takeda, Toshihiro (AUTHOR)
Okamoto, Hiroshi (AUTHOR)
Hori, Masatsugu (AUTHOR)
Sakata, Yasushi (AUTHOR)
Fujio, Yasushi (AUTHOR)
Tsunoda, Shirley M. (AUTHOR)
Pokaż więcej
Źródło:
PLoS ONE. 3/7/2024, Vol. 19 Issue 3, p1-14. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic analysis and molecular basis of G6PD deficiency among malaria patients in Thailand: implications for safe use of 8-aminoquinolines.
Autorzy:
Boonyuen, Usa (AUTHOR)
Jacob, Beatriz Aira C. (AUTHOR)
Wongwigkan, Jutamas (AUTHOR)
Chamchoy, Kamonwan (AUTHOR)
Singha-art, Natsamon (AUTHOR)
Pengsuk, Natnicha (AUTHOR)
Songdej, Duantida (AUTHOR)
Adams, Emily R. (AUTHOR)
Edwards, Thomas (AUTHOR)
Chamnanchanunt, Supat (AUTHOR)
Amran, Syazwani Itri (AUTHOR)
Latif, Nurriza Ab (AUTHOR)
Louis, Naveen Eugene (AUTHOR)
Chandran, Shamini (AUTHOR)
Pokaż więcej
Źródło:
Malaria Journal. 2/2/2024, Vol. 23 Issue 1, p1-17. 17p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Autorzy:
Shen L; Department of Cardiology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Cosmi D; Department of Cardiology, Hospital of Gubbio, Gubbio, Italy.
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cosmi F; Department of Cardiology, Hospital of Cortona, Cortona, Italy.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Staszewsky L; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, UK.
Huynh T; McGill Health University Center, Division of Cardiology, Montreal, Quebec, Canada.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, SC, USA.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2019 Aug; Vol. 21 (8), pp. 974-984. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*physiopathology
Insulin/*therapeutic use
Stroke Volume/*physiology
Ventricular Function, Left/*physiology
Aged ; Cause of Death/trends ; Diabetes Mellitus, Type 2/complications ; Female ; Global Health ; Heart Failure/diagnosis ; Heart Failure/mortality ; Hospitalization/trends ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Survival Rate/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of Pro-BNP in predicting outcome in acute heart failure patient presenting to a medical emergency: An observational study from North India.
Autorzy:
Singhal, Arjun (AUTHOR)
Singh, Gaurav (AUTHOR)
Singh, S (AUTHOR)
Karunanand, Busi (AUTHOR)
Agrawal, Sonu (AUTHOR)
Pokaż więcej
Źródło:
Journal of Family Medicine & Primary Care. Dec2023, Vol. 12 Issue 12, p3156-3159. 4p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Short-term study of atrial shunt and improvement of functional mitral regurgitation.
Autorzy:
Shang, Xiaoke (AUTHOR)
Liu, Mei (AUTHOR)
Zhong, Yucheng (AUTHOR)
Wang, Xueli (AUTHOR)
Chen, Song (AUTHOR)
Fu, Xiaojuan (AUTHOR)
Sun, Ming (AUTHOR)
Li, Geng (AUTHOR)
Xie, Mingxing (AUTHOR)
Song, Guangyuan (AUTHOR)
Zhu, Da (AUTHOR)
Zhang, Changdong (AUTHOR)
Dong, Nianguo (AUTHOR)
Pokaż więcej
Źródło:
Journal of Cardiothoracic Surgery. 11/15/2023, Vol. 18 Issue 1, p1-11. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
Autorzy:
Taylor, Walter R. J. (AUTHOR)
Meagher, Niamh (AUTHOR)
Ley, Benedikt (AUTHOR)
Thriemer, Kamala (AUTHOR)
Bancone, Germana (AUTHOR)
Satyagraha, Ari (AUTHOR)
Assefa, Ashenafi (AUTHOR)
Chand, Krisin (AUTHOR)
Chau, Nguyen Hoang (AUTHOR)
Dhorda, Mehul (AUTHOR)
Degaga, Tamiru S. (AUTHOR)
Ekawati, Lenny L. (AUTHOR)
Hailu, Asrat (AUTHOR)
Hasanzai, Mohammad Anwar (AUTHOR)
Naddim, Mohammad Nader (AUTHOR)
Pasaribu, Ayodhia Pitaloka (AUTHOR)
Rahim, Awab Ghulam (AUTHOR)
Sutanto, Inge (AUTHOR)
Thanh, Ngo Viet (AUTHOR)
Tuyet-Trinh, Nguyen Thi (AUTHOR)
Pokaż więcej
Źródło:
PLoS Neglected Tropical Diseases. 9/6/2023, Vol. 17 Issue 9, p1-18. 18p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Autorzy:
Cannon JA; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Shen L; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Jhund PS; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Anand IS; Division of Cardiology, University of Minnesota, Minneapolis, MN, USA.
Komajda M; Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France.
McKelvie RS; Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
Zile MR; Ralph H. Johnsons Veterans Affairs Medical Center and, Medical University of South Carolina, Charleston, SC, USA.
Carson PE; Georgetown University and Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
McMurray JJ; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2016 Aug; Vol. 18 (8), pp. 1021-31. Date of Electronic Publication: 2016 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Biphenyl Compounds/*therapeutic use
Bundle-Branch Block/*physiopathology
Heart Failure/*drug therapy
Tetrazoles/*therapeutic use
Aged ; Bundle-Branch Block/complications ; Cause of Death ; Female ; Heart Failure/blood ; Heart Failure/complications ; Heart Failure/physiopathology ; Hospitalization/statistics & numerical data ; Humans ; Irbesartan ; Male ; Middle Aged ; Mortality ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Proportional Hazards Models ; Severity of Illness Index ; Stroke Volume ; Systole
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Indications for cardiac resynchronization therapy: 2011 update from the heart failure society of america guideline committee.
Autorzy:
Stevenson WG
Hernandez AF
Carson PE
Fang JC
Katz SD
Spertus JA
Sweitzer NK
Tang WH
Albert NM
Butler J
Westlake Canary CA
Collins SP
Colvin-Adams M
Ezekowitz JA
Givertz MM
Hershberger RE
Rogers JG
Teerlink JR
Walsh MN
Stough WG
Pokaż więcej
Źródło:
Journal of Cardiac Failure; Feb2012, Vol. 18 Issue 2, p94-106, 13p
Czasopismo naukowe
Szczegóły
Tytuł:
Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019.
Autorzy:
Sun, Jiahong (AUTHOR)
Qiao, Yanan (AUTHOR)
Zhao, Min (AUTHOR)
Magnussen, Costan G. (AUTHOR)
Xi, Bo (AUTHOR)
Pokaż więcej
Źródło:
BMC Medicine. 6/26/2023, Vol. 21 Issue 1, p1-15. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study.
Autorzy:
Nguyen, Chi (AUTHOR)
Bamber, Luke (AUTHOR)
Willey, Vincent J (AUTHOR)
Evers, Thomas (AUTHOR)
Power, Thomas P (AUTHOR)
Stephenson, Judith J (AUTHOR)
Pokaż więcej
Źródło:
Patient Preference & Adherence. May2023, Vol. 17, p1181-1196. 16p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Autorzy:
Kao DP; University of Colorado School of Medicine, Aurora, CO, USA.
Lewsey JD; University of Glasgow, Glasgow, UK.
Anand IS; Veterans Affairs Medical Center and University of Minnesota, Minneapolis, MN, USA.
Massie BM; University of California San Francisco, San Francisco, CA, USA.
Zile MR; Medical University of South Carolina and the RHF Department of Veterans Affairs Medical Center, Charleston, SC, USA.
Carson PE; Washington Veterans Affairs Medical Center and Georgetown University, Washington, DC, USA.
McKelvie RS; Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.
Komajda M; University Pierre et Marie Curie Paris VI, La Pitié-Salpétrière Hospital Paris, France.
McMurray JJ; University of Glasgow, Glasgow, UK.
Lindenfeld J; University of Colorado School of Medicine, Aurora, CO, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2015 Sep; Vol. 17 (9), pp. 925-35. Date of Electronic Publication: 2015 Aug 06.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biphenyl Compounds/*administration & dosage
Heart Failure/*physiopathology
Stroke Volume/*physiology
Tetrazoles/*administration & dosage
Aged ; Aged, 80 and over ; Angiotensin II ; Angiotensin II Type 1 Receptor Blockers/administration & dosage ; Cause of Death/trends ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Heart Failure/drug therapy ; Heart Failure/mortality ; Humans ; Irbesartan ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Survival Rate/trends ; United Kingdom/epidemiology ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 2385

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies